senate Bill S7440A

2015-2016 Legislative Session

Relates to the use of oral medications by optometrists

download bill text pdf

Sponsored By

Archive: Last Bill Status - Passed Senate


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (8)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 17, 2016 referred to higher education
Jun 16, 2016 delivered to assembly
passed senate
ordered to third reading cal.1939
committee discharged and committed to rules
Jun 13, 2016 print number 7440a
Jun 13, 2016 amend and recommit to higher education
May 02, 2016 referred to higher education

Co-Sponsors

view additional co-sponsors

S7440 - Details

See Assembly Version of this Bill:
A9961
Current Committee:
Assembly Higher Education
Law Section:
Education Law
Laws Affected:
Amd §§7101-a & 7104, Ed L
Versions Introduced in Other Legislative Sessions:
2017-2018: S5235, A6751
2019-2020: S4035, A1193

S7440 - Summary

Relates to the use of oral medications by optometrists.

S7440 - Sponsor Memo

S7440 - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  7440

                            I N  S E N A T E

                               May 2, 2016
                               ___________

Introduced  by  Sen.  FUNKE  -- read twice and ordered printed, and when
  printed to be committed to the Committee on Higher Education

AN ACT to amend the education law, in relation to the use of oral  medi-
  cations  by  optometrists;  and  providing  for  the repeal of certain
  provisions upon expiration thereof

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Paragraph  (e)  of subdivision 1 of section 7101-a of the
education law, as added by chapter 517 of the laws of 1995,  is  amended
to read as follows:
  (e) [Phase one] TOPICAL therapeutic pharmaceutical agents. [Phase one]
TOPICAL  THERAPEUTIC  pharmaceutical agents shall mean those drugs which
shall be limited to topical application to the surface of  the  eye  for
therapeutic purposes and shall be limited to:
  (i) antibiotic/antimicrobials;
  (ii) decongestants/anti-allergenics;
  (iii) non-steroidal anti-inflammatory agents;
  (iv) steroidal anti-inflammatory agents;
  (v) antiviral agents;
  (vi) hyperosmotic/hypertonic agents;
  (vii) cycloplegics;
  (viii) artificial tears and lubricants; AND
  (IX) IMMUNOSUPPRESSIVE AGENTS.
  S 2. Paragraph (f) of subdivision 1 of section 7101-a of the education
law,  as added by chapter 517 of the laws of 1995, is amended to read as
follows:
  (f) [Phase two  therapeutic]  THERAPEUTIC  pharmaceutical  agents  FOR
TREATMENT  OF GLAUCOMA AND OCULAR HYPERTENSION.  [Phase two] THERAPEUTIC
pharmaceutical agents FOR TREATMENT OF GLAUCOMA AND OCULAR  HYPERTENSION
shall  mean those drugs which shall be limited to topical application to
the surface of the eye and shall be limited to:
  (i) beta blockers;
  (ii) alpha agonists;
  (iii) direct acting cholinergic agents;

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.

Co-Sponsors

view additional co-sponsors

S7440A (ACTIVE) - Details

See Assembly Version of this Bill:
A9961
Current Committee:
Assembly Higher Education
Law Section:
Education Law
Laws Affected:
Amd §§7101-a & 7104, Ed L
Versions Introduced in Other Legislative Sessions:
2017-2018: S5235, A6751
2019-2020: S4035, A1193

S7440A (ACTIVE) - Summary

Relates to the use of oral medications by optometrists.

S7440A (ACTIVE) - Sponsor Memo

S7440A (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7440--A

                            I N  S E N A T E

                               May 2, 2016
                               ___________

Introduced   by  Sens.  FUNKE,  ADDABBO,  ESPAILLAT,  GALLIVAN,  LITTLE,
  MARCHIONE, O'MARA, ORTT, RITCHIE, SERINO, SEWARD,  VALESKY,  YOUNG  --
  read  twice  and  ordered printed, and when printed to be committed to
  the Committee  on  Higher  Education  --  committee  discharged,  bill
  amended,  ordered reprinted as amended and recommitted to said commit-
  tee

AN ACT to amend the education law, in relation to the use of oral  medi-
  cations  by  optometrists;  and  providing  for  the repeal of certain
  provisions upon expiration thereof

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Paragraph  (e)  of subdivision 1 of section 7101-a of the
education law, as added by chapter 517 of the laws of 1995,  is  amended
to read as follows:
  (e) [Phase one] TOPICAL therapeutic pharmaceutical agents. [Phase one]
TOPICAL  THERAPEUTIC  pharmaceutical agents shall mean those drugs which
shall be limited to topical application to the surface of  the  eye  for
therapeutic purposes and shall be limited to:
  (i) antibiotic/antimicrobials;
  (ii) decongestants/anti-allergenics;
  (iii) non-steroidal anti-inflammatory agents;
  (iv) steroidal anti-inflammatory agents;
  (v) antiviral agents;
  (vi) hyperosmotic/hypertonic agents;
  (vii) cycloplegics;
  (viii) artificial tears and lubricants; AND
  (IX) IMMUNOSUPPRESSIVE AGENTS.
  S 2. Paragraph (f) of subdivision 1 of section 7101-a of the education
law,  as added by chapter 517 of the laws of 1995, is amended to read as
follows:
  (f) [Phase two  therapeutic]  THERAPEUTIC  pharmaceutical  agents  FOR
TREATMENT  OF GLAUCOMA AND OCULAR HYPERTENSION.  [Phase two] THERAPEUTIC
pharmaceutical agents FOR TREATMENT OF GLAUCOMA AND OCULAR  HYPERTENSION
shall  mean those drugs which shall be limited to topical application to
the surface of the eye and shall be limited to:
  (i) beta blockers;
  (ii) alpha agonists;

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.